News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.

Subscribe

Santa Cruz discontinued a large number of its polyclonal products as a result of the USDA settlement that was made public May 19th 2016

Find CST Equivalent

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

Western Blotting

Western blot analysis of p38 MAPK Control Cell extracts using Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP® Rabbit mAb

#4511 (upper) and p38 MAPK Antibody #9212 (lower).

Learn more about how we get our images
Image
Image
Image
Image
Image
Image

Product Description

Nonphosphorylated p38 MAPK Control Cell Extracts: Total extracts from C-6 glioma cells prepared without anisomycin treatment to serve as a negative control. Supplied in SDS Sample Buffer.

Phosphorylated p38 MAPK Control Cell Extracts: Total extracts from C-6 glioma cells prepared with anisomycin treatment to serve as a positive control. Supplied in SDS Sample Buffer.


p38 MAP kinase (MAPK), also called RK (1) or CSBP (2), is the mammalian orthologue of the yeast HOG kinase that participates in a signaling cascade controlling cellular responses to cytokines and stress (1-4). Four isoforms of p38 MAPK, p38α, β, γ (also known as Erk6 or SAPK3), and δ (also known as SAPK4) have been identified. Similar to the SAPK/JNK pathway, p38 MAPK is activated by a variety of cellular stresses including osmotic shock, inflammatory cytokines, lipopolysaccharide (LPS), UV light, and growth factors (1-5). MKK3, MKK6, and SEK activate p38 MAPK by phosphorylation at Thr180 and Tyr182. Activated p38 MAPK has been shown to phosphorylate and activate MAPKAP kinase 2 (3) and to phosphorylate the transcription factors ATF-2 (5), Max (6), and MEF2 (5-8).

SB203580 (4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-imidazole) is a selective inhibitor of p38 MAPK. This compound inhibits the activation of MAPKAPK-2 by p38 MAPK and subsequent phosphorylation of HSP27 (9). SB203580 inhibits p38 MAPK catalytic activity by binding to the ATP-binding pocket, but does not inhibit phosphorylation of p38 MAPK by upstream kinases (10).


1.  Rouse, J. et al. (1994) Cell 78, 1027-37.

2.  Han, J. et al. (1994) Science 265, 808-11.

3.  Lee, J.C. et al. (1994) Nature 372, 739-46.

4.  Freshney, N.W. et al. (1994) Cell 78, 1039-49.

5.  Raingeaud, J. et al. (1995) J Biol Chem 270, 7420-6.

6.  Zervos, A.S. et al. (1995) Proc Natl Acad Sci U S A 92, 10531-4.

7.  Zhao, M. et al. (1999) Mol Cell Biol 19, 21-30.

8.  Yang, S.H. et al. (1999) Mol Cell Biol 19, 4028-38.

9.  Cuenda, A. et al. (1995) FEBS Lett 364, 229-33.

10.  Kumar, S. et al. (1999) Biochem Biophys Res Commun 263, 825-31.



For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

9213
p38 MAPK Control Cell Extracts